KR20110110069A - A composition containing lindera obtusiloba leaf extract for skin whitening and wrinkle treatment - Google Patents
A composition containing lindera obtusiloba leaf extract for skin whitening and wrinkle treatment Download PDFInfo
- Publication number
- KR20110110069A KR20110110069A KR1020110078734A KR20110078734A KR20110110069A KR 20110110069 A KR20110110069 A KR 20110110069A KR 1020110078734 A KR1020110078734 A KR 1020110078734A KR 20110078734 A KR20110078734 A KR 20110078734A KR 20110110069 A KR20110110069 A KR 20110110069A
- Authority
- KR
- South Korea
- Prior art keywords
- leaf extract
- composition
- ginger
- present
- skin whitening
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- 230000002087 whitening effect Effects 0.000 title claims abstract description 25
- 230000037303 wrinkles Effects 0.000 title claims abstract description 12
- 206010040954 Skin wrinkling Diseases 0.000 title description 10
- 240000006370 Lindera obtusiloba Species 0.000 title description 2
- 235000012857 Lindera obtusiloba Nutrition 0.000 title description 2
- 241000234314 Zingiber Species 0.000 claims abstract description 26
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 26
- 235000008397 ginger Nutrition 0.000 claims abstract description 26
- 239000002537 cosmetic Substances 0.000 claims abstract description 13
- 230000006872 improvement Effects 0.000 claims abstract description 10
- 235000013376 functional food Nutrition 0.000 claims abstract description 9
- 235000000665 Lycianthes asarifolia Nutrition 0.000 claims description 31
- 241000866517 Lycianthes asarifolia Species 0.000 claims description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract description 38
- 210000003491 skin Anatomy 0.000 abstract description 24
- 210000002615 epidermis Anatomy 0.000 abstract description 18
- 210000002752 melanocyte Anatomy 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 15
- 239000000049 pigment Substances 0.000 abstract description 10
- 102000004169 proteins and genes Human genes 0.000 abstract description 10
- 108090000623 proteins and genes Proteins 0.000 abstract description 10
- 230000019612 pigmentation Effects 0.000 abstract description 8
- 230000036564 melanin content Effects 0.000 abstract description 7
- 230000001153 anti-wrinkle effect Effects 0.000 abstract description 6
- 230000003061 melanogenesis Effects 0.000 abstract description 5
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 230000009471 action Effects 0.000 abstract description 2
- 230000001747 exhibiting effect Effects 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 15
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- 238000010171 animal model Methods 0.000 description 9
- 208000012641 Pigmentation disease Diseases 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 230000008099 melanin synthesis Effects 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 238000007447 staining method Methods 0.000 description 7
- 208000001382 Experimental Melanoma Diseases 0.000 description 6
- 102000013760 Microphthalmia-Associated Transcription Factor Human genes 0.000 description 6
- 108010050345 Microphthalmia-Associated Transcription Factor Proteins 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 102000003425 Tyrosinase Human genes 0.000 description 6
- 108060008724 Tyrosinase Proteins 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- 229960005070 ascorbic acid Drugs 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 208000002109 Argyria Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010051246 Photodermatosis Diseases 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000357 carcinogen Toxicity 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- -1 for example Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 230000008845 photoaging Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 101000668058 Infectious salmon anemia virus (isolate Atlantic salmon/Norway/810/9/99) RNA-directed RNA polymerase catalytic subunit Proteins 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 210000001787 dendrite Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Birds (AREA)
- Polymers & Plastics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Nutrition Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 생강나무 잎 추출물을 포함하는 피부 미백 및 주름개선용 화장료 조성물 또는 기능성 식품 조성물을 제공한다. 본 발명의 미백 효과 및 주름 개선 효과는 멜라닌 함유량의 감소, 멜라닌 생성에 관여하는 단백질의 발현 저해, UVB 에 의해 색소침착을 유도한 마우스의 멜라노사이트에서의 멜라노솜 생성 억제, 표피에 분포하는 멜라닌 색소의 감소, 표피의 두께 감소 등의 작용을 통하여 확인된다. 따라서 본 발명에 따른 생강나무 잎 추출물을 포함하는 조성물은 부작용이 없고 뛰어난 효능의 피부 미백효과 또는 피부 주름개선 효과를 나타내는 화장료 조성물 또는 기능성 식품 조성물로 이용될 수 있다.The present invention provides a cosmetic composition or functional food composition for skin whitening and anti-wrinkle containing ginger tree leaf extract. The whitening and anti-wrinkle effect of the present invention is to reduce melanin content, inhibit the expression of protein involved in melanogenesis, inhibit melanocyte formation in melanocytes of melanocytes induced pigmentation by UVB, melanin pigment distributed in the epidermis It is confirmed by the action of reducing the thickness of the epidermis and reducing the thickness of the epidermis. Therefore, the composition comprising the ginger tree leaf extract according to the present invention can be used as a cosmetic composition or a functional food composition having no side effects and exhibiting skin whitening effect or skin wrinkle improvement effect of excellent efficacy.
Description
본 발명은 피부 미백용 조성물에 관한 것으로서, 보다 상세하게는 생강나무 잎 추출물을 포함하는 피부 미백 및/또는 주름개선용 조성물에 관한 것이다.The present invention relates to a composition for skin whitening, and more particularly to a composition for skin whitening and / or anti-wrinkle comprising ginger tree leaf extract.
피부 미백에 효과적이라고 알려진 물질로는 비타민 C, 상백피 추출물, 코지산(kojic acid), 알부틴(arbutin), 감초 추출물, 하이드로퀴논(hydroquinone) 등이 있다. 코지산은 발암성 물질로 밝혀져 실험 외에는 화장품 성분으로 사용이 금지되어 있으며, 하이드로퀴논은 멜라노사이트(melanocyte)에 대한 독성이 있고, 생체내실험(in vivo test) 결과 영구 탈색의 위험성이 있으며 발암물질로도 알려져 국내에서 화장품 성분으로 수입이 금지된 상태이다. 상기와 같이 공지된 화학물질은 미백 효과는 있더라도 피부에 대한 독성 내지 부작용의 문제가 수반되어 그 이용에는 한계가 있는 실정이다. 따라서 최근에는 피부에 대한 부작용을 최소화 할 수 있는 천연물 유래의 피부 미백 성분을 개발하고자 하는 연구가 활발히 이루어지고 있다.Substances known to be effective in skin whitening include vitamin C, lettuce extract, kojic acid, arbutin, licorice extract, and hydroquinone. Koji acid except been identified as a carcinogen, and experimental use is prohibited as a cosmetic ingredient, hydroquinone are toxic to melanocytes (melanocyte), in vivo (in As a result of the in vivo test, there is a risk of permanent discoloration, and it is also known as a carcinogen, and it is prohibited to import as a cosmetic ingredient in Korea. Known chemicals as described above, although there is a whitening effect, it is accompanied by a problem of toxicity or side effects on the skin, and its use is limited. Therefore, in recent years, researches are being actively conducted to develop skin whitening ingredients derived from natural products which can minimize side effects on the skin.
생강나무(Lindera obtusiloba BL.)는 우리나라, 일본, 중국 등지에 분포하는 쌍떡잎식물 미나리아재비목 녹나무과의 낙엽관목이며, 그 꽃은 관상용으로, 가지와 잎, 열매는 식용으로 이용되고 있다. 또한 그 가지와 나무 껍질은 약용으로도 이용되며, 타박상의 어혈과 산후에 몸이 붓고 팔다리가 아픈 증세 등에 효과가 있는 것으로 알려져 있다. 그러나 생강나무의 피부 미백 또는 주름개선과 관련된 효능에 대해서는 현재까지 연구되거나 알려진 바 없다.Ginger tree ( Lindera obtusiloba BL.) is a deciduous shrub of the dicotyledonous plant of the genus Trifoliaceae, which is distributed in Korea, Japan and China, and its flowers are used for ornamental purposes, and its branches, leaves, and fruits are used for food. The branches and bark are also used for medicinal purposes, and are known to be effective for bruising fish and postpartum swelling and limb pain. However, the effects associated with skin whitening or wrinkle improvement of ginger tree have not been studied or known to date.
본 발명자들은 부작용이 적고 안전성이 확보되면서도 우수한 피부 미백 및 주름개선 효과를 나타내는 소재를 천연물로부터 개발하고자 연구를 거듭하였으며, 그 결과, 우리나라 전역에 다량 서식하나 크게 활용되지 못하고 있었던 생강나무의 잎을 원료로 하는 추출물로부터, 우수한 피부 미백 및 주름개선 효능을 확인함으로써 본 발명을 완성하게 되었다.The present inventors have conducted research to develop a material from natural products that exhibits excellent skin whitening and wrinkle improvement effects with less side effects and ensures safety, and as a result, the leaves of ginger trees, which have been in large quantities throughout Korea but have not been widely utilized, are used as raw materials. From the extract to make excellent skin whitening and wrinkle improvement efficacy was completed the present invention.
본 발명의 목적은 독성 및 부작용이 없으면서도 우수한 효능을 나타내는 피부 미백 및/또는 주름개선을 위한 조성물을 제공하고자 하는 것이다.It is an object of the present invention to provide a composition for skin whitening and / or wrinkle improvement that exhibits excellent efficacy without toxicity and side effects.
이러한 본 발명의 목적은 생강나무 잎 추출물을 포함하는 피부 미백 및/또는 주름개선용 화장료 조성물 또는 기능성 식품 조성물이나 약학 조성물 등의 형태로 제공함으로써 달성될 수 있다.The object of the present invention can be achieved by providing in the form of a cosmetic composition or functional food composition or pharmaceutical composition for skin whitening and / or anti-wrinkle including ginger tree leaf extract.
본 발명에 따른 생강나무 잎 추출물을 포함하는 조성물은 천연물을 원료로 하여 피부에 대한 독성 내지 부작용의 문제를 해결할 수 있을 뿐만 아니라 우수한 피부 미백 및 주름개선 효과를 나타낸다. 본 발명의 미백 효과 및 주름 개선 효과는 멜라닌 함유량의 감소, 멜라닌 생성에 관여하는 단백질의 발현 저해, UVB 에 의해 색소침착을 유도한 마우스의 멜라노사이트에서의 멜라노솜 생성 억제, 표피에 분포하는 멜라닌 색소의 감소, 표피의 두께 감소 등의 작용을 통하여 확인된다. 따라서 본 발명에 따른 생강나무 잎 추출물을 포함하는 조성물은 부작용이 없고 뛰어난 효능의 피부 미백효과 또는 피부 주름개선 효과를 나타내는 화장료 조성물 또는 기능성 식품 조성물로 이용될 수 있다.The composition comprising the ginger tree leaf extract according to the present invention can solve the problem of toxicity or side effects on the skin by using natural products as well as exhibits excellent skin whitening and wrinkle improvement effect. The whitening and anti-wrinkle effect of the present invention is to reduce melanin content, inhibit the expression of protein involved in melanogenesis, inhibit melanocyte formation in melanocytes of melanocytes induced pigmentation by UVB, melanin pigment distributed in the epidermis It is confirmed by the action of reducing the thickness of the epidermis and reducing the thickness of the epidermis. Therefore, the composition comprising the ginger tree leaf extract according to the present invention can be used as a cosmetic composition or a functional food composition having no side effects and exhibiting skin whitening effect or skin wrinkle improvement effect of excellent efficacy.
도 1은 B16 멜라노마 F10 세포주에 생강나무 잎 추출물 1, 5, 10, 50 ㎍/㎖을 72시간 동안 처리한 후 멜라닌 함유량을 확인한 결과이다.
도 2는 B16 멜라노마 F10 세포주에 생강나무 잎 추출물 10, 50 ㎍/㎖을 72시간 동안 처리한 후 웨스턴 블롯팅 기법을 통해 멜라닌 합성에 관여하는 단백질의 발현을 확인한 결과이다.
도 3은 실험동물에 생강나무 잎 추출물을 경구투여 후 3, 6, 9주 마다 실험동물의 귀 조직에서 멜라노사이트 활성을 도파 염색법을 통하여 나타낸 사진이다.
도 4는 실험동물에 생강나무 잎 추출물을 경구투여 후 3, 6, 9주 마다 실험동물의 귀 조직에서 멜라닌 색소 분포도를 폰타나 메이슨 염색법을 통하여 나타낸 사진이다.Figure 1 shows the results of confirming the melanin content after treatment with
Figure 2 shows the results of confirming the expression of proteins involved in melanin synthesis through Western blotting technique after treatment for 10 hours, 50 ㎍ / ㎖ ginger leaf extract for 72 hours to B16 melanoma F10 cell line.
Figure 3 is a photograph showing the melanocyte activity in the ear tissues of experimental animals every 3, 6, 9 weeks after oral administration of ginger tree leaf extract to the experimental animals through the waveguide staining method.
Figure 4 is a photograph showing the melanin distribution in the ear tissues of experimental animals every 3, 6, 9 weeks after oral administration of ginger tree leaf extract to the experimental animals through Fontana Mason staining method.
본 발명은 생강나무 잎 추출물을 포함하는 피부 미백 및/또는 주름개선용 조성물을 제공하며, 보다 구체적으로 생강나무 잎 추출물을 포함하는 화장료 조성물 또는 기능성 식품 조성물을 제공한다.The present invention provides a skin whitening and / or anti-wrinkle composition comprising a ginger tree leaf extract, and more specifically provides a cosmetic composition or functional food composition comprising a ginger tree leaf extract.
본 발명에 있어서, 생강나무 잎 추출물이라 함은 물, 탄소수 1 내지 4의 저급 알코올 및 이들의 혼합용매로 이루어진 군 중에서 선택된 극성용매로부터의 추출물이며, 바람직하게는 70% 에탄올로부터의 추출물을 의미한다. In the present invention, the ginger leaf extract is an extract from a polar solvent selected from the group consisting of water, a lower alcohol having 1 to 4 carbon atoms, and a mixed solvent thereof, and preferably means an extract from 70% ethanol. .
상기 생강나무 잎 추출물을 얻기 위하여 당업계에서 통상 사용되는 추출방법을 사용하며, 예를 들면 원료인 생강나무 잎 중량의 5~20배, 바람직하게는 10~20배의 용매로 20~100℃, 바람직하게는 65~85℃의 추출온도에서 1시간~2일, 바람직하게는 2시간~1일 동안 1회~3회 반복 추출하며, 환류 추출, 초음파 추출 등의 방법을 적용할 수 있다.In order to obtain the ginger tree leaf extract using an extraction method commonly used in the art, for example, 20 to 100 ℃ as a solvent of 5-20 times the weight of the ginger tree leaf, preferably 10-20 times the raw material, Preferably, extraction is repeated once to three times for 1 hour to 2 days, preferably 2 hours to 1 day, at an extraction temperature of 65 to 85 ° C., and methods such as reflux extraction and ultrasonic extraction may be applied.
본 발명에 따른 생강나무 잎 추출물은, 바람직하게는 조성물 총 중량에 대하여 0.001~50 중량%로 포함된다. Ginger leaf extract according to the present invention, preferably contained in 0.001 to 50% by weight relative to the total weight of the composition.
본 발명의 조성물을 멜라노마 세포주에 처리하였을 때 멜라닌 함유량의 감소, 멜라닌 생성에 관여하는 단백질의 발현 저해가 확인되었으며, 본 발명의 조성물을 UVB에 의해 색소침착을 유도한 마우스에 경구투여하였을 때 멜라노사이트에서의 멜라노솜 생성 억제, 표피에 분포하는 멜라닌 색소의 감소, 표피의 두께 감소가 확인되었다. 따라서 본 발명에 따른 생강나무 잎 추출물을 포함하는 조성물은 피부에 직접 적용하는 화장료 조성물 또는 경구 투여하는 기능성 식품 조성물로서 우수한 피부 미백 및 주름 개선 효과를 나타낼 수 있다. Decreased melanin content and inhibition of expression of proteins involved in melanogenesis were observed when the composition of the present invention was treated to melanoma cell lines, and the composition of the present invention was orally administered to mice induced with pigmentation by UVB. Inhibition of melanoma production at the site, reduction of melanin pigments distributed in the epidermis, and reduction of the thickness of the epidermis were confirmed. Therefore, the composition comprising the ginger tree leaf extract according to the present invention may exhibit an excellent skin whitening and wrinkle improvement effect as a cosmetic composition or a functional food composition to be administered orally directly applied to the skin.
본 발명의 조성물이 화장료 조성물인 경우, 화장료 조성물에 포함되는 성분은 생강나무 잎 추출물 이외에 화장품 조성물에 통상적으로 이용되는 성분들을 포함하며, 예를 들어 항산화제, 안정화제, 용제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함할 수 있다. 또한 상기 화장료 조성물은 그 효과를 증진시키기 위해 피부 흡수 촉진제를 추가로 포함할 수 있다.When the composition of the present invention is a cosmetic composition, the components included in the cosmetic composition include components commonly used in cosmetic compositions in addition to ginger leaf extract, for example, antioxidants, stabilizers, solvents, vitamins, pigments and flavorings. Conventional adjuvants such as, and carriers. In addition, the cosmetic composition may further include a skin absorption enhancer to enhance the effect.
본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 또는 스프레이 등으로 제형화될 수 있다. 보다 상세하게는 유연 화장수, 영양 화장수, 영양 크림, 마사지 크림, 에센스, 아이 크림, 클렌징 크림, 클렌징 폼, 클렌징 워터, 팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다.Cosmetic compositions of the present invention can be prepared in any formulation conventionally prepared in the art, for example solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, soaps, oils, powder foundations, emulsions It may be formulated as a liquid foundation, wax foundation, spray or the like. More specifically, it may be prepared in the form of a flexible lotion, nutrition lotion, nutrition cream, massage cream, essence, eye cream, cleansing cream, cleansing foam, cleansing water, pack, spray or powder.
본 발명에 따른 생강나무 잎 추출물은 화장료 총 중량에 대해 0.001~5중량%의 양으로 첨가되어 사용될 수 있지만 이에 한정되는 것은 아니다.Ginger leaf extract according to the present invention may be used in an amount of 0.001 to 5% by weight based on the total weight of the cosmetic, but is not limited thereto.
또한 본 발명의 조성물은 기능성 식품일 수 있다. 본 발명의 기능성 식품 조성물에 포함되는 성분은 생강나무 잎 추출물 이외에 식품에 통상적으로 이용되는 첨가제를 포함하며, 예를 들어 착향제, 산미제, 보존제, 감미제, 산화방지제, 안정제, 착색제 및 영양강화제 등을 포함할 수 있다.In addition, the composition of the present invention may be a functional food. Ingredients included in the functional food composition of the present invention includes additives commonly used in foods in addition to ginger leaf extract, for example, flavoring, acidulant, preservatives, sweeteners, antioxidants, stabilizers, colorants and nutrition enhancers, etc. It may include.
물론, 본 발명에 따른 조성물은 주사제와 같은 약물이나 알약의 형태로 제형화될 수도 있다.Of course, the compositions according to the invention may also be formulated in the form of drugs or pills, such as injections.
본 발명에 따른 생강나무 잎 추출물은 식품 총 중량에 대해 1~20 중량%의 양으로 첨가되어 사용될 수 있지만 이에 한정되는 것은 아니다.Ginger leaf extract according to the present invention can be used in an amount of 1 to 20% by weight based on the total weight of the food, but is not limited thereto.
이하에서는 본 발명을 실시예 및 실험예를 들어 구체적으로 서술하나, 이는 본 발명을 예시하는 것일 뿐 본 발명이 이로써 제한되는 것은 아니다.
Hereinafter, the present invention will be described in detail with reference to Examples and Experimental Examples, which are merely illustrative of the present invention and the present invention is not limited thereto.
실시예Example 1 : 생강나무 추출물의 제조 1: Preparation of Ginger Extract
생강나무 잎을 세척하고 물기를 제거한 후 -80℃에서 동결시킨 후 동결건조를 하여 파우더화 하였다. 파우더 상태의 잎 100 g에 70% 에탄올을 시료 중량의 10 배 분량으로 첨가하고 80℃에서 4 시간씩 3 회 반복 추출하였다. 추출액을 40℃에서 감압 농축, 동결 건조하여 분말을 얻었다. 수득율은 26.8 % 였으며, 수득한 분말을 이하의 실험에 사용하였다.The ginger leaves were washed and dried to freeze at -80 ℃ and then lyophilized to powder. 70% ethanol was added to 100 g of the leaf in the
다만, 실시예 1에 기재된 생강나무 추출물의 제조방법은 일 예일 뿐이고 에탄올의 농도와 온도 및 시간 등의 조건은 변경될 수 있으며 일반적으로 공지된 다른 다양한 추출방법에 의할 수도 있다. 다만 생강나무 추출물의 제조조건이 변화될 경우 수득율 등이 다소 달라질 수는 있다.
However, the preparation method of the ginger tree extract described in Example 1 is only one example, and conditions such as concentration and temperature and time of ethanol may be changed, and may be based on various other known extraction methods. However, if the manufacturing conditions of the ginger tree extract is changed, the yield may vary slightly.
실험예Experimental Example 1 : One : 생체외(Ex vivo ( In vitroIn vitro )에서의) In 멜라닌 함유량 측정 Melanin content measurement
본 발명에 따른 생강나무 잎 추출물의 멜라닌 생성 저해 효능을 확인하기 위해, B16 멜라노마 F10 세포주를 대상으로 한 생체외 실험으로 멜라닌 함유량의 변화를 측정하였다.In order to confirm the melanin production inhibitory effect of the ginger leaf extract according to the present invention, the change of melanin content was measured by an in vitro experiment with B16 melanoma F10 cell line.
측정방법은 하기와 같다. B16 멜라노마 F10 세포주를 24 웰-플레이트에 웰 당 세포수 1 X 104로 분주한 후 부착이 확인되면, 상기 실시예 1에서 얻은 생강나무 잎 추출물을 1, 5, 10, 50 ㎍/㎖ 의 농도별로 처리하여 DMEM (Dulcco's Modifeid Eagle Medium)과 함께 72시간 동안 37 ℃, 5 % CO2 인큐베이터에서 배양하였다. 72시간이 지나면 웰의 세포를 PBS로 두 번 세척한 후 1 N NaOH로 용해(lysis)시켰다. 470 nm의 흡광도에서 멜라닌 양을 측정하였다.The measuring method is as follows. When the B16 melanoma F10 cell line was dispensed at 1 x 10 4 cells per well into 24 well-plates and adhesion was confirmed, the ginger leaf extract obtained in Example 1 was 1, 5, 10, 50 μg / ml. Each concentration was treated with DMEM (Dulcco's Modifeid Eagle Medium) and incubated for 72 hours at 37 ℃, 5% CO 2 incubator. After 72 hours, the cells in the wells were washed twice with PBS and then lysed with 1 N NaOH. The melanin amount was measured at an absorbance of 470 nm.
측정 결과, 도 1에 나타내었듯이, B16 멜라노마 F10 세포주의 총 멜라닌 함유량은 생강나무 잎 추출물의 전 처리군에서 10% 이상 감소하였다. 특히 생강나무 잎 추출물 50 ㎍/㎖ 처리군에서 멜라닌 양은 22% 감소하였다. 이는 세포의 증식을 억제하지 않는 범위에서 세포 내 총 멜라닌 양이 크게 감소한 결과이다. 이로써 본 발명에 따른 생강나무 잎 추출물은 멜라닌을 감소시킴으로써 미백 효과를 나타냄을 확인할 수 있었다.
As a result, as shown in Figure 1, the total melanin content of the B16 melanoma F10 cell line was reduced by more than 10% in the pre-treated group of ginger leaf extract. In particular, the amount of melanin was decreased by 22% in the 50 ㎍ / ㎖ ginger leaf extract treatment group. This is the result of a significant decrease in the total amount of melanin in the cells in the range that does not inhibit the proliferation of the cells. As a result, the ginger leaf extract according to the present invention was confirmed to exhibit a whitening effect by reducing melanin.
실험예Experimental Example 2 : 멜라닌 합성에 관여하는 단백질 발현 측정 2: measurement of protein expression involved in melanin synthesis
본 발명에 따른 생강나무 잎 추출물의 멜라닌 생성 저해 효능을 확인하기 위해, 멜라닌 생성에 관여하는 단백질인 ERK (Extracelluar signal-regulated kinase), MITF(Microphthalmia-associated transcription factor), 그리고 티로시나아제(tyrosinase)를 대상으로 단백질 발현 정도를 측정하였다.In order to confirm the melanin production inhibitory effect of the ginger leaf extract according to the present invention, the protein involved in melanogenesis, ERK (Extracelluar signal-regulated kinase), MITF (Microphthalmia-associated transcription factor), and tyrosinase (tyrosinase) Protein expression was measured in the subject.
ERK는 세포 증식과 분화에 관여하는 중요 신호 매개자(signaling mediator)이며, ERK 신호전달 경로(signaling pathway)는 멜라닌 생성에 관여하며, ERK 신호전달 경로의 저해는 과색소침착 (hyperpigmentation)을 유발하는 것으로 알려져 있다. MITF (Microphthalmia-associated transcription factor)는 색소침착, 증식, 그리고 멜라노사이트의 생존에 관여한다. 또한 MITF는 티로시나아제와 티로시나아제 연관 단백질-1 (tyrosinase relate protein-1, TRP-1)에도 강하게 관여하는 중요한 단백질로 알려져 있다. 티로시나아제는 멜라닌 합성에 직접 관련된 가장 중요한 효소로 잘 알려져 있다.ERK is an important signaling mediator involved in cell proliferation and differentiation, ERK signaling pathway is involved in melanogenesis and inhibition of ERK signaling pathway causes hyperpigmentation. Known. Microphthalmia-associated transcription factor (MITF) is involved in pigmentation, proliferation, and survival of melanocytes. MITF is also known to be an important protein strongly involved in tyrosinase and tyrosinase relate protein-1 (TRP-1). Tyrosinase is well known as the most important enzyme that is directly involved in melanin synthesis.
측정방법은 하기와 같다. B16 멜라노마 F10 세포주를 24 웰-플레이트에 웰 당 세포수 1 X 104로 분주한 후 부착이 확인되면, 상기 실시예 1에서 얻은 생강나무 잎 추출물을 10, 50 ㎍/㎖ 의 농도별로 처리하여 DMEM (Dulcco's Modifeid Eagle Medium)과 함께 72 시간 동안 37 ℃, 5 % CO2 인큐베이터에서 배양하였다. 72 시간이 지나면 웰의 세포를 PBS로 두 번 세척한 후 용해 버퍼〔조성: 62.5 mM 트리스-HCl (pH 6.8), 2 % SDS, 5 % β-머캅토에탄올, 프로테아제 저해제 (CompleteTM, 로슈, 만하임, 독일), 2 mM 페닐메틸술포닐플루오라이드, 10 mM EDTA, 50 mM NaF, 및 1 mM Na3VO4] 로 세포를 모아 단백질을 추출하였다.The measuring method is as follows. When the B16 melanoma F10 cell line was dispensed in 24 well-plates at a cell number of 1 X 10 4 per well, and then adhesion was confirmed, the ginger leaf extract obtained in Example 1 was treated at a concentration of 10 and 50 ㎍ / ml. Incubated with DMEM (Dulcco's Modifeid Eagle Medium) for 72 hours in a 37 ° C., 5% CO 2 incubator. After 72 hours, the cells in the wells were washed twice with PBS, followed by lysis buffer [composition: 62.5 mM Tris-HCl (pH 6.8), 2% SDS, 5% β-mercaptoethanol, protease inhibitors (Complete ™ , Roche, Mannheim, Germany), 2 mM phenylmethylsulfonylfluoride, 10 mM EDTA, 50 mM NaF, and 1 mM Na 3 VO 4 ] to collect the cells and extract proteins.
각 10 ㎍의 단백질을 SDS-폴리아크릴아미드 겔을 이용해 전기영동 한 후 PVDF 멤브레인에 이동 (transfer)시켰다. 멤브레인을 5 % 건조 밀크(dried milk)로 블로킹한 후 5 % BSA와 함께 1:1000으로 1차 항체 희석하여 밤새 냉장하였다. 화학발광 (Chemiluminescence) 플러스 키트 (Amersham International, Little Chalfont, 영국)를 이용하여 현상하였다.Each 10 μg of protein was electrophoresed using SDS-polyacrylamide gel and then transferred to the PVDF membrane. The membrane was blocked with 5% dried milk and then refrigerated overnight with 1: 1000 primary antibody dilution with 5% BSA. Development was performed using a Chemiluminescence Plus Kit (Amersham International, Little Chalfont, UK).
측정 결과, 도 2에 나타내었듯이, 생강나무 잎 추출물은 ERK의 발현을 증가시켰으며, MITF 및 티로시나아제의 발현은 억제시켰다. 따라서 본 발명에 따른 생강나무 잎 추출물은 멜라닌을 감소시킴으로써 미백 효과를 나타냄을 확인할 수 있었다.
As a result, as shown in Figure 2, the ginger leaf extract increased the expression of ERK, and inhibited the expression of MITF and tyrosinase. Therefore, the ginger leaf extract according to the present invention was confirmed to exhibit a whitening effect by reducing melanin.
실험예Experimental Example 3 : 3: 도파Wave 염색법을 통한 Through staining 멜라노사이트Melanosite 활성 관찰 Active observation
본 발명에 따른 생강나무 잎 추출물의 경구투여에 의한 멜라닌 생성 저해 효능을 확인하기 위해, UVB 조사로 실험동물에 색소침착을 유도하고 생강나무 잎 추출물을 경구투여한 후 도파 염색법에 의해 멜라노사이트의 활성을 관찰하였다.In order to confirm the inhibitory effect of melanin production by oral administration of the ginger leaf extract according to the present invention, induction of pigmentation in the experimental animal by UVB irradiation and oral administration of the ginger tree leaf extract and the activity of melanocytes by dopa staining method Was observed.
측정을 위해 실험동물은 하기와 같이 처리하였다. 실험동물로는 C57BL/6 종의 암컷(18 g, 8주령)을 사용하였으며 코아텍(KOATEK, 인천, 한국)에서 구입하여 1주일간 적응시킨 후 non-UVB 군과 UVB 군으로 나누어 10일 동안 오전에 100 mJ/cm2의 UVB를 조사하여 색소침착을 유도한 후, 표 1에서와 같이 non-UVB 군(각 군의 개체수 n=15마리), only-UVB 군, 아스코르브산(70 mg/kg) 경구투여군, 상기 실시예 1에서 얻은 생강나무 잎 추출물 경구투여 3개군(40 mg/kg, 80 mg/kg, 120 mg/kg)으로 나누어 9주간 사육하였다.For the measurement, the experimental animals were treated as follows. C57BL / 6 females (18 g, 8 weeks old) were used as experimental animals and were purchased from KOATEK (KOATEK, Incheon, Korea) for 1 week, then divided into non-UVB and UVB groups for 10 days in the morning. After irradiating UVB at 100 mJ / cm 2 , pigmentation was induced, and as shown in Table 1, the non-UVB group (n = 15 in each group), only-UVB group, and ascorbic acid (70 mg / kg) ) Oral administration group, ginger tree leaf extract obtained in Example 1 orally administered three groups (40 mg / kg, 80 mg / kg, 120 mg / kg) were divided into 9 weeks breeding.
실험군(생강나무 잎 추출물 투여군)
Experimental group (ginger tree leaf extract administration group)
도 3은 경구 투여 3, 6, 9주 마다 실험군 당 5마리씩 희생하여 귀 조직에서 멜라노사이트 활성을 도파 염색(dopa-staining)을 통하여 나타낸 사진이다. 도파 염색은 표피에 있는 멜라노사이트의 수를 알 수 있는 특징을 갖는 면역학적 조직 염색법이다. UVB 100 mJ/cm2에서 10일 동안 조사를 하게 되면 색소침착의 유도가 잘된다. 관찰 결과, UVB 조사 후 세포의 수는 조사 이전에 비해 3-4배 증가하였고 크기도 커졌으며 수상돌기가 현저히 발달하였다. UVB 조사 중단 후 20주까지는 조사 이전보다 증가한 상태가 유지되었다. 생강나무 잎 추출물을 농도 별로 경구 투여를 하게 되면 멜라닌 세포의 증식에 영향을 미치게 되어 멜라닌 색소 형성 억제 작용을 나타내는 것을 관찰할 수 있었다. 생강나무 잎 추출물 40 mg/kg에서는 억제 작용이 다른 농도와 비교시 미약함을 관찰할 수 있었으나, only UVB 조사군과 비교해 보면 멜라닌 세포의 수와 크기가 감소됨을 확인할 수 있었다. 생강나무 잎 추출물 80 mg/kg과 120 mg/kg은 비슷한 양상을 보였으며 아스코르브산 70 mg/kg과도 비슷하거나 조금 더 우수한 멜라닌 색소 억제 작용이 있음을 알 수 있었다. 따라서 본 발명에 따른 생강나무 잎 추출물은 경구투여에 의해서도 멜라닌을 감소시킴으로써 미백 효과를 나타냄을 확인할 수 있었다.
FIG. 3 is a photograph showing melanocyte activity in dorsal tissues by dopa-staining at the expense of 5 mice per experimental group every 3, 6 and 9 weeks of oral administration. Dopa staining is an immunological tissue staining method characterized by knowing the number of melanocytes in the epidermis. Irradiation at
실험예Experimental Example 4 : 특수염색법을 통한 멜라닌 색소의 분포 관찰 4: Observation of the distribution of melanin pigment by special staining method
본 발명에 따른 생강나무 잎 추출물의 경구투여에 의한 멜라닌 생성 저해 효능을 확인하기 위해, UVB 조사로 실험동물에 색소침착을 유도하고 생강나무 잎 추출물을 경구투여한 후 폰타나 메이슨 실버(Fontana-Masson silver) 염색법에 의해 표피 전 층의 멜라닌 세포 분포를 관찰하였다.In order to confirm the inhibitory effect of melanin production by oral administration of the ginger leaf extract according to the present invention, induction of pigmentation in the experimental animal by UVB irradiation and oral administration of ginger tree leaf extract Fontana Mason silver (Fontana-Masson silver) ) Melanocyte distribution in the entire epidermal layer was observed by staining.
실험동물의 처리 및 실험군은 상기 실시예 3과 동일하게 하였다.Treatment of experimental animals and experimental groups were the same as in Example 3.
도 4는 경구투여 3, 6, 9주 마다 실험군 당 5마리씩 희생하여 귀 조직에서 멜라닌 색소 분포도를 폰타나 마손 실버 염색을 통하여 나타낸 사진이다. 폰타나 마손 실버 염색은 표피 전 층에 걸쳐 분포하는 멜라닌 색소를 확인할 수 있는 면역학적 조직 염색법이다. 관찰 결과, Only UVB 조사군을 보면 표피 전 층에 걸쳐 멜라닌 색소가 분포하게 됨을 알 수 있었다. 그러나 아스코르브산이나 생강나무 잎 추출물을 투여하게 되면 3/6/9주로 갈수록 표피 일부 층에서만 멜라닌 색소의 분포를 확인할 수 있었으며, 생강나무 잎 추출물 80 mg/kg, 120 mg/kg 농도의 투여군을 양성 대조군인 아스코르브산 70 mg/kg과 비교해 보면 표피 층의 멜라닌 색소가 비슷하거나 조금 더 적음을 관찰할 수 있었다. 따라서 본 발명에 따른 생강나무 잎 추출물은 경구투여에 의해서도 멜라닌을 감소시킴으로써 미백 효과를 나타냄을 확인할 수 있었다.Figure 4 is a photograph showing the distribution of melanin pigment in the ear tissue by Fontana Masson silver staining at the expense of 5 per experimental group every 3, 6, 9 weeks oral administration. Fontana Masson silver staining is an immunological tissue staining method that can identify melanin pigments distributed throughout the epidermal layer. As a result, only UVB irradiation group showed melanin pigment distribution throughout the epidermal layer. However, when ascorbic acid or ginger leaf extract was administered to 3/6/9 weeks, the distribution of melanin was found only in a part of the epidermis, and the positive dose group of 80 mg / kg and 120 mg / kg of ginger leaf extract was positive. Compared with the control group 70 mg / kg ascorbic acid, the melanin pigment in the epidermal layer was similar or slightly less. Therefore, the ginger leaf extract according to the present invention was confirmed to exhibit a whitening effect by reducing melanin even by oral administration.
한편, 상기 폰타나 메이슨 실버 염색법을 통해, 표피의 두께 변화도 관찰할 수 있었다. 도 4에서 나타내었듯이, 조사되는 자외선에 의해 표피 층이 두꺼워짐을 알 수 있었다. 그러나 생강나무 잎 추출물을 경구투여 하게 되면 시간이 지남에 따라 얇아지는 표피 층을 확인할 수 있었다. 표피 층이 두꺼워지는 것은 광노화에 의한 조기 노화에 의한 것이다. 즉, 자외선이 몸에 쌓이면서 피부 층이 두꺼워지고 멜라노사이트가 증가되고 콜라겐의 형성이 감소하고 엘라스틴 섬유도 딱딱해져 피부에 주름살이 생기고 늘어지는 탄력섬유 변성 증상이 나타나 피부가 노화되는 것이다. 생강나무 잎 추출물을 투여함으로써 이러한 광노화를 막을 수 있음을 확인하였으며, 따라서 본 발명에 따른 생강나무 잎 추출물은 피부 주름 개선 효과를 나타냄을 알 수 있었다.On the other hand, it was also possible to observe the thickness change of the epidermis through the Fontana and Mason silver staining method. As shown in FIG. 4, it was found that the epidermal layer was thickened by the ultraviolet rays irradiated. However, oral administration of Ginger leaf extract could identify the epidermal layer thinning over time. The thickening of the epidermal layer is due to premature aging due to photoaging. That is, as ultraviolet rays accumulate on the body, the skin layer becomes thicker, melanocytes increase, collagen formation decreases, elastin fibers harden, wrinkles appear on the skin, and elastic fiber degeneration symptoms appear. It was confirmed that this photoaging can be prevented by administering the ginger leaf extract, and thus, the ginger leaf extract according to the present invention showed an improvement in skin wrinkles.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110078734A KR20110110069A (en) | 2011-08-08 | 2011-08-08 | A composition containing lindera obtusiloba leaf extract for skin whitening and wrinkle treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110078734A KR20110110069A (en) | 2011-08-08 | 2011-08-08 | A composition containing lindera obtusiloba leaf extract for skin whitening and wrinkle treatment |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080130799A Division KR101209220B1 (en) | 2008-12-22 | 2008-12-22 | A composition containing Lindera obtusiloba leaf extract for skin whitening and wrinkle treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20110110069A true KR20110110069A (en) | 2011-10-06 |
Family
ID=45026912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110078734A KR20110110069A (en) | 2011-08-08 | 2011-08-08 | A composition containing lindera obtusiloba leaf extract for skin whitening and wrinkle treatment |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20110110069A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160121268A (en) | 2015-04-10 | 2016-10-19 | 디랑(주) | Anti-aging composition comprising Cannabis satica extract |
-
2011
- 2011-08-08 KR KR1020110078734A patent/KR20110110069A/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160121268A (en) | 2015-04-10 | 2016-10-19 | 디랑(주) | Anti-aging composition comprising Cannabis satica extract |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20150139688A (en) | The Extract Of The Citrus grandis Osbeck Having Skin Whitening Activity And Cosmetic Composition Containing The Same | |
US7189419B2 (en) | Use of active extracts to lighten skin, lips, hair, and/or nails | |
KR20210004156A (en) | Composition for improving winkle or skin whitening comprising atriplex gmelinii extract or paederia scandens extract | |
KR20130060130A (en) | Composition for skin whitening comprising kadsura coccinea extract | |
KR101131574B1 (en) | Composition for skin whitening | |
KR101860109B1 (en) | Skin external composition containing floral ginsenoside | |
KR102158780B1 (en) | Composition for improving skin comprising natural material extract | |
JPWO2017138652A1 (en) | Melanin degradation inhibitor | |
KR101209220B1 (en) | A composition containing Lindera obtusiloba leaf extract for skin whitening and wrinkle treatment | |
US20040126344A1 (en) | Compositions having glycolipid to lighten skin and alter post-inflammatory hyperpigmentation | |
KR101095609B1 (en) | Cosmetic composition containing whitening Composition for whitening Skin | |
KR101203504B1 (en) | Composition for Wrinkle-Care or Skin Whitening Containing Fermentation Liquor of Extract from Stewartia koreana | |
KR20140120245A (en) | Composition for skin whitening containing corn silk extract | |
KR100678864B1 (en) | Cosmetic composition for skin whitening comprising cnidium officinale extract and carnitine as active ingredient | |
KR20110110069A (en) | A composition containing lindera obtusiloba leaf extract for skin whitening and wrinkle treatment | |
KR101303294B1 (en) | The cosmetic composition for removing melasma, age spot, freckles and promoting desquamation containing Eclipta prostrate, wheat bud and Hovenia dulcia | |
KR20170137412A (en) | Composition for improving skin condition comprising herb extracts mixture | |
KR100678865B1 (en) | Cosmetic composition for skin whitening comprising ramulus mori extract and carnitine as active ingredient | |
KR101526435B1 (en) | Compositions for skin-whitening comprising extract of Vitis amurensis ruprecht | |
KR101515443B1 (en) | The functional cosmetic composition for anti-wrinkle, skin whitening and recovery of distrupted skin containing, comprising the mixture of extract of bergamot, Lonicera japonica Thunberg, Coix lachryma-jobi var. mayuen and wheat bud | |
KR102526200B1 (en) | Composition for Skin Moisturizing and Whitening Comprising Decurcinol as Active Ingredient | |
KR102626704B1 (en) | Composition for promoting hair growth comprising rose petal extract as an active ingredient | |
KR20120129598A (en) | The cosmetic composition for skin whitening comprising the mixture of extract of Hovenia dulcia, Platycodon grandiflorum, wheat bud and sage | |
KR100561781B1 (en) | Composition for skin whitening containing extract of Sinomenium acutum | |
WO2017145958A1 (en) | Whitening agent comprising as active agent syzygium polyanthum or an extract thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |